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Background
The induction of mucosal immunity is a crucial goal for
HIV vaccines. DNA vaccines which are non-live/non-pro-
liferating have had limited success in this area. Mucosal
immune cell homing is in part controlled by a subset of
chemokines (CCL27, CCL28 and CCL25). We hypothe-
sized that a DNA vaccine encoding antigen and chemok-
ine could induce mucosal immunity.
Methods
Mice were systemically co-immunized with pHIV-1gag/
pol and chemokine adjuvants. Rhesus macaques (n = 5/
group) were immunized intramuscularly with antigenic
plasmids plus/minus each chemokine. For rhesus opti-
mized CCL27, CCL25, and CCL28 plasmids, optimized/
consensus macaque pol and sooty mangabey consensus
gag/env plasmids were generated.
Results
Mice: Co-immunization with chemokines induced signif-
icant enhancement of HIV-1 specific CD8+ T cell IFN-
gamma secretion in the periphery and TNF-alpha, IL-2
and IFN-gamma by gut lymphocytes. Co-immunization
with mucosal chemokines augmented HIV-1-specific sIgA
in sera/fecal samples. Similar immunogenicity data was
observed to Influenza A/PR8/34 hemagglutanin plasmid
including responses that neutralized virus and protected
mice from morbidity/mortality associated with lethal
mucosal challenge. Macaque: In the periphery, we
observed significant IFN-gamma in all groups (~6,000
SFU each). However intracellular cytokine staining on
mucosal lymphocytes showed a trend toward an increase
in CD8+T cells secreting TNF and IL-2 in CCL27 co-
immunized macaques, levels greater than those observed
in infected animals. Enhanced antigen-specific IgA was
also detected in sera of chemokine-vaccinated macaques.
A mucosal challenge is scheduled to determine if the func-
tionality and phenotype of vaccine-induced immunity,
either at the mucosa or periphery, is a driving determinant
of protection.
Conclusion
The results of this study will be critical to the development
of an effective vaccine against HIV. This is the first exam-
ple of the use of mucosal chemokines to influence a DNA
vaccine strategy, suggesting a novel approach for manipu-
lation of vaccine-induced immune responses. This work is
supported by NIH funding (HIVRAD).
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